http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006019954-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e29526f284c0155fd79806c9dd5a1c7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-537 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537 |
| filingDate | 2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4813d8d27aba2b45667792595d9cae |
| publicationDate | 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2006019954-A1 |
| titleOfInvention | Method for reducing the likelihood of the occurrence of cardiac arrhythmias |
| abstract | A method is described for reducing the likelihood of the occurrence of a cardiac arrhythmias of the type leading to sudden cardiac death in a mammalian subject. The method comprises administering to the mammalian subject an effective amount of a composition to agonize β 3 adrenergic receptors in the mammalian subject. The composition may comprise one or more agents that are known to agonize β 3 adrenergic receptors, such as BRL 37344, CPG 12177, CL 316243, SR 58661, pindolol, and cyanopindolol. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149837-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016046763-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023028602-A1 |
| priorityDate | 2004-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 239.